Literature DB >> 27558422

CD95 Signaling Inhibits B Cell Receptor-Mediated Gammaherpesvirus Replication in Apoptosis-Resistant B Lymphoma Cells.

Lingbing Tan1, Chaocan Zhang1, Julien Dematos2, Linlin Kuang1, Jae U Jung3, Xiaozhen Liang4.   

Abstract

While CD95 is an apoptosis-inducing receptor and has emerged as a potential anticancer therapy target, mounting evidence shows that CD95 is also emerging as a tumor promoter by activating nonapoptotic signaling pathways. Gammaherpesviral infection is closely associated with lymphoproliferative diseases, including B cell lymphomas. The nonapoptotic function of CD95 in gammaherpesvirus-associated lymphomas is largely unknown. Here, we show that stimulation of CD95 agonist antibody drives the majority of sensitive gammaherpesvirus-transformed B cells to undergo caspase-dependent apoptosis and promotes the survival and proliferation of a subpopulation of apoptosis-resistant B cells. Surprisingly, CD95-mediated nonapoptotic signaling induced beta interferon (IFN-β) expression and correlatively inhibited B cell receptor (BCR)-mediated gammaherpesviral replication in the apoptosis-resistant lymphoma cells without influencing BCR signaling. Further analysis showed that IFN-β alone or synergizing with CD95 blocked the activation of lytic switch proteins and the gene expression of gammaherpesviruses. Our findings indicate that, independent of its apoptotic activity, CD95 signaling activity plays an important role in blocking viral replication in apoptosis-resistant, gammaherpesvirus-associated B lymphoma cells, suggesting a novel mechanism that indicates how host CD95 prototype death receptor controls the life cycle of gammaherpesviruses independent of its apoptotic activity. IMPORTANCE: Gammaherpesviruses are closely associated with lymphoid malignancies and other cancers. Viral replication and persistence strategies leading to cancer involve the activation of antiapoptotic and proliferation programs, as well as evasion of the host immune response. Here, we provide evidence that the stimulation of CD95 agonist antibody, mimicking one of the major mechanisms of cytotoxic T cell killing, inhibits B cell receptor-mediated gammaherpesviral replication in CD95 apoptosis-resistant lymphoma cells. CD95-induced type I interferon (IFN-β) contributes to the inhibition of gammaherpesviral replication. This finding sheds new light on the CD95 nonapoptotic function and provides a novel mechanism for gammaherpesviruses that helps them to escape host immune surveillance.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27558422      PMCID: PMC5068529          DOI: 10.1128/JVI.00668-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Fas engagement accelerates liver regeneration after partial hepatectomy.

Authors:  J Desbarats; M K Newell
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

2.  Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations.

Authors:  R M Siegel; J K Frederiksen; D A Zacharias; F K Chan; M Johnson; D Lynch; R Y Tsien; M J Lenardo
Journal:  Science       Date:  2000-06-30       Impact factor: 47.728

3.  EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53.

Authors:  Christophe Le Clorennec; Ibtissam Youlyouz-Marfak; Eric Adriaenssens; Jean Coll; Georg W Bornkamm; Jean Feuillard
Journal:  Blood       Date:  2005-11-29       Impact factor: 22.113

4.  The CD95 receptor: apoptosis revisited.

Authors:  Marcus E Peter; Ralph C Budd; Julie Desbarats; Stephen M Hedrick; Anne-Odile Hueber; M Karen Newell; Laurie B Owen; Richard M Pope; Juerg Tschopp; Harald Wajant; David Wallach; Robert H Wiltrout; Martin Zörnig; David H Lynch
Journal:  Cell       Date:  2007-05-04       Impact factor: 41.582

5.  A novel murine anti-human Fas mAb which mitigates lymphadenopathy without hepatotoxicity.

Authors:  K Ichikawa; H Yoshida-Kato; M Ohtsuki; J Ohsumi; J Yamaguchi; S Takahashi; Y Tani; M Watanabe; A Shiraishi; K Nishioka; S Yonehara; N Serizawa
Journal:  Int Immunol       Date:  2000-04       Impact factor: 4.823

6.  Fas signaling promotes motility and metastasis through epithelial-mesenchymal transition in gastrointestinal cancer.

Authors:  H X Zheng; Y D Cai; Y D Wang; X B Cui; T T Xie; W J Li; L Peng; Y Zhang; Z Q Wang; J Wang; B Jiang
Journal:  Oncogene       Date:  2012-04-16       Impact factor: 9.867

7.  Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1.

Authors:  E Flemington; S H Speck
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

8.  Modulation of caspase-8 and FLICE-inhibitory protein expression as a potential mechanism of Epstein-Barr virus tumorigenesis in Burkitt's lymphoma.

Authors:  C G Tepper; M F Seldin
Journal:  Blood       Date:  1999-09-01       Impact factor: 22.113

Review 9.  The many roles of FAS receptor signaling in the immune system.

Authors:  Andreas Strasser; Philipp J Jost; Shigekazu Nagata
Journal:  Immunity       Date:  2009-02-20       Impact factor: 31.745

10.  NF-kappaB inhibits gammaherpesvirus lytic replication.

Authors:  Helen J Brown; Moon Jung Song; Hongyu Deng; Ting-Ting Wu; Genhong Cheng; Ren Sun
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

View more
  5 in total

1.  CD95-CD95L interaction mediates the growth control of MHV68 immortalized B cells by cytotoxic T cells.

Authors:  Sihan Dong; Lingbing Tan; Guifang Chen; Xiaozhen Liang
Journal:  Virol Sin       Date:  2017-06       Impact factor: 4.327

2.  Regulation of gammaherpesvirus lytic replication by endoplasmic reticulum stress-induced transcription factors ATF4 and CHOP.

Authors:  Xing-Chen Zhou; Si-Han Dong; Zhong-Shun Liu; Shuai Liu; Chao-Can Zhang; Xiao-Zhen Liang
Journal:  J Biol Chem       Date:  2018-01-05       Impact factor: 5.157

3.  Inhibition of Herpes Simplex Virus-1 Replication by Natural Compound Honokiol.

Authors:  Shuai Liu; Long Li; Lingbing Tan; Xiaozhen Liang
Journal:  Virol Sin       Date:  2019-03-26       Impact factor: 4.327

Review 4.  Virus Infection and Death Receptor-Mediated Apoptosis.

Authors:  Xingchen Zhou; Wenbo Jiang; Zhongshun Liu; Shuai Liu; Xiaozhen Liang
Journal:  Viruses       Date:  2017-10-27       Impact factor: 5.048

5.  Interleukin 16 contributes to gammaherpesvirus pathogenesis by inhibiting viral reactivation.

Authors:  Shuai Liu; Zhangmengxue Lei; Jie Li; Liu Wang; Ran Jia; Zhongshun Liu; Congwei Jiang; Ying Gao; Mu Liu; Linlin Kuang; Zhikang Qian; Dongming Zhou; Samuel H Speck; Xiaozhen Liang
Journal:  PLoS Pathog       Date:  2020-07-31       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.